Nuclear N-Glycosylation Redefines the Glycoscape and Directs Cell Identity
preprint
OA: closed
Abstract
SUMMARY Glycans modify nucleic acids, proteins and lipids in fundamental biological processes, but have long been considered confined to the secretory pathway and cell surface. Here, we challenge this view with evidence that N-glycosylation, a ubiquitous glycan modification, occurs within cell nuclei across tissues and species, exhibiting cell type-dependent abundance and localization patterns. Using a multi-faceted approach, we show that numerous classical membrane and secreted glycoproteins localize to the nucleus with N-glycan modifications, exemplified by the cell adhesion molecule L1CAM. Mechanistically, we show that the N-glycosylated L1CAM is transported to the nucleus by KPNB1, where it transcriptionally modulates neuronal differentiation. Moreover, this nuclear N-glycosylation event contributes to neurodevelopmental disorders and is pharmacologically reversible. These findings revise the cellular geography of N-glycosylation and expand the known routes of protein trafficking, and highlight nuclear N-glycosylation pathways as potential therapeutic entry points for developmental disorders.
Full text
1,926 characters
· extracted from
oa-doi-fallback
· click to expand
Nuclear N-Glycosylation Redefines the Glycoscape and Directs Cell Identity
SUMMARY
Glycans modify nucleic acids, proteins and lipids in fundamental biological processes, but have long been considered confined to the secretory pathway and cell surface. Here, we challenge this view with evidence that N-glycosylation, a ubiquitous glycan modification, occurs within cell nuclei across tissues and species, exhibiting cell type-dependent abundance and localization patterns. Using a multi-faceted approach, we show that numerous classical membrane and secreted glycoproteins localize to the nucleus with N-glycan modifications, exemplified by the cell adhesion molecule L1CAM. Mechanistically, we show that the N-glycosylated L1CAM is transported to the nucleus by KPNB1, where it transcriptionally modulates neuronal differentiation. Moreover, this nuclear N-glycosylation event contributes to neurodevelopmental disorders and is pharmacologically reversible. These findings revise the cellular geography of N-glycosylation and expand the known routes of protein trafficking, and highlight nuclear N-glycosylation pathways as potential therapeutic entry points for developmental disorders.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
↵11 Lead contact
Funder Information Declared
Subject Area
- Biochemistry (17714)
- Bioengineering (13906)
- Bioinformatics (42001)
- Biophysics (21469)
- Cancer Biology (18624)
- Cell Biology (25533)
- Clinical Trials (138)
- Developmental Biology (13390)
- Ecology (19932)
- Epidemiology (2067)
- Evolutionary Biology (24350)
- Genetics (15616)
- Genomics (22529)
- Immunology (17752)
- Microbiology (40430)
- Molecular Biology (17200)
- Neuroscience (88679)
- Paleontology (667)
- Pathology (2840)
- Pharmacology and Toxicology (4828)
- Physiology (7653)
- Plant Biology (15160)
- Synthetic Biology (4304)
- Systems Biology (9826)
- Zoology (2271)
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00